Maastricht University, Department of Radiotherapy/GROW School for Oncology and Developmental Biology/CAPHRI Care and Public Health, Research Institute, P. O. Box 616, 6200 MD Maastricht, the Netherlands.
Zuyd University of Applied Sciences, Zuyd Health, Research Centre Autonomy and Participation for Persons with a Chronic Illness, Nursing Department, Heerlen, the Netherlands; Maastricht University, Department of Family Medicine/CAPHRI Care and Public Health, Research Institute, Nieuw Eyckholt 300, 6419 DJ Heerlen, Maastricht, the Netherlands.
Patient Educ Couns. 2020 Jan;103(1):145-151. doi: 10.1016/j.pec.2019.07.024. Epub 2019 Jul 24.
Effective healthcare innovations are often not adopted and implemented. An implementation strategy based on facilitators and barriers for use as perceived by healthcare professionals could increase adoption rates. This study therefore aimed to identify the most relevant facilitators and barriers for use of an innovative breast cancer aftercare decision aid (PtDA) in healthcare practice.
Facilitators and barriers (related to the PtDA, adopter and healthcare organisation) were assessed among breast cancer aftercare health professionals (n = 81), using the MIDI questionnaire. For each category, a backward regression analysis was performed (dependent = intention to adopt). All significant factors were then added to a final regression analysis to identify to most relevant determinants of PtDA adoption.
Expecting higher compatibility with daily practice and clinical guidelines, more positive outcomes of use, higher perceived relevance for the patient and increased self-efficacy were significantly associated with a higher intention to adopt. Self-efficacy and perceived patient relevance remained significant in the final model.
Low perceived self-efficacy and patient relevance are the most important barriers for health professions to adopt a breast cancer aftercare PtDA.
To target self-efficacy and perceived patient relevance, the implementation strategy could apply health professional peer champions.
有效的医疗保健创新往往没有得到采用和实施。基于医疗保健专业人员认为的使用促进因素和障碍的实施策略可以提高采用率。因此,本研究旨在确定在医疗保健实践中使用创新型乳腺癌康复决策辅助工具(PtDA)的最相关促进因素和障碍。
使用 MIDI 问卷评估了乳腺癌康复保健专业人员(n=81)对 PtDA、采用者和医疗保健组织的促进因素和障碍的看法。对于每个类别,都进行了反向回归分析(因变量=采用意向)。然后,将所有显著因素添加到最终回归分析中,以确定最相关的 PtDA 采用决定因素。
期望与日常实践和临床指南的更高兼容性、更高的使用效果、更高的感知相关性对患者和更高的自我效能与更高的采用意向显著相关。自我效能和感知到的患者相关性在最终模型中仍然具有统计学意义。
低自我效能和感知到的患者相关性是医疗保健专业人员采用乳腺癌康复 PtDA 的最大障碍。
为了针对自我效能和感知到的患者相关性,实施策略可以应用医疗保健专业人员的同行拥护者。